SCHEMBL6560836

SCHEMBL6560836

CCS(=O)(=O)N(Cc1ccncc1)C1CC(C)(C)Oc2ccc(C(N)=O)cc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 4/20 0.34
ALDH1A1 P00352 2/20 0.34
PKM P14618 1/20 0.34
HTT P42858 1/20 0.34
RECQL P46063 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HSD17B10 Q99714 1/20 0.34
HTR1A P08908 1/20 0.33
HTR1D P28221 1/20 0.33
HTR2C P28335 1/20 0.33
CYP17A1 P05093 1/20 0.32
KCNE1 P15382 6/20 0.32
KCNQ1 P51787 6/20 0.32
CCNC P24863 1/20 0.32
CDK8 P49336 1/20 0.32
HASPIN Q8TF76 1/20 0.32
F10 P00742 1/20 0.31
ROCK2 O75116 1/20 0.31
PSEN1 P49768 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6559544 0.92 KCNA5 (0.36) KCNA5ALDH1A1PKMHTTRECQL
SCHEMBL6559403 0.89 KCNA5 (0.37) KCNA5ALDH1A1PKMHTTRECQL
SCHEMBL6559386 0.84 KCNA5 (0.39) KCNA5ALDH1A1HTR1AHTR1DHTR2C
SCHEMBL6559388 0.81 KCNE1 (0.43) KCNA5HTR1AHTR1DHTR2CKCNE1
SCHEMBL7826743 0.79 KCNE1 (0.36) KCNA5HTR1AHTR1DHTR2CKCNE1
SCHEMBL6559500 0.78 NPSR1 (0.38) KCNA5SMN1; SMN2NPSR1KCNE1KCNQ1
SCHEMBL6559208 0.77 KCNE1 (0.46) KCNA5HTR1AHTR1DHTR2CKCNE1
SCHEMBL6559205 0.75 SMN1; SMN2 (0.38) KCNA5ALDH1A1HTTSMN1; SMN2NPSR1
SCHEMBL6560808 0.75 KCNE1 (0.41) HTR1AHTR1DHTR2CKCNE1KCNQ1
SCHEMBL6559927 0.75 KCNA5 (0.41) KCNA5ALDH1A1KCNE1KCNQ1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0807629-B1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them AVENTIS PHARMA GMBH (DE) 2004-03-03 EP disclosed
US-6191164-B1 POTASSIUM CHANNEL MODULATORS; ANTIULCER AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 2001-02-20 US disclosed
EP-0807629-A1 Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents aswell as medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1997-11-19 EP disclosed